Magnesium as a conformational gatekeeper of KRAS : Structural dynamics and therapeutic implications
Protein Science · 2026
DOI: 10.1002/pro.70681 ↗At a glance
Journal article in Protein Science, 2026. Written by Bindu Y Srinivasu and 6 co-authors. Institution: Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA. Major MEDLINE topics: Proto-Oncogene Proteins p21(ras), Magnesium, SOS1 Protein. Cited 1 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIH HHS, NCI NIH HHS, National Institutes of Health.
Abstract (original language)
Magnesium serves as an essential cofactor for small GTPases, yet its structural role in regulating KRAS conformational dynamics and nucleotide exchange remains poorly understood. Here, we combine hydrogen–deuterium exchange mass spectrometry (HDX‐MS), native mass spectrometry, and functional assays to elucidate how Mg 2+ stabilizes the KRAS conformational ensemble and constrains transitions between GDP‐ and GTP‐bound states. Depletion of Mg 2+ triggers widespread increases in structural dynamics throughout KRAS—spanning the p‐loop, α 1‐helix, switch I, nucleotide‐binding region, and distal helices—revealing a global loosening of the protein fold that favors an open, nucleotide exchange‐competent state. Mg 2+ titration experiments demonstrate that individual structural elements exhibit distinct Mg 2+ dependencies: the p‐loop and α 1‐helix recover native dynamics at micromolar concentrations, whereas switch I requires millimolar levels, underscoring its exceptionally high sensitivity to Mg 2+ for structural stabilization. KRAS bound to the catalytic domain of exchange factor SOS1 displays an HDX signature closely resembling the Mg 2+ ‐free state, indicating that SOS1 promotes nucleotide exchange by transiently perturbing Mg 2+ coordination while simultaneously stabilizing switch I. Consistently, the phosphomimetic KRAS S17E variant, which disrupts a critical Mg 2+ ‐coordinating residue, exhibits pronounced global destabilization—reinforcing the central importance of Mg 2+ in maintaining structural integrity. Taken together, our findings show that Mg 2+ acts as a master regulator of KRAS structural dynamics and reveal Mg 2+ ‐sensitive hotspots that might represent promising targets for next‐generation KRAS therapeutics.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, USA.
- Department of Radiation Oncology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA.
- Department of Biochemistry, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA.
ORCID profiles: Bindu Y Srinivasu, Tanvi S Damerla, Alexander Stec, Zhiwei Zhou, John R Engen, Kenneth D Westover, Thomas E Wales
Funding
- NIH HHS
- NCI NIH HHS
- National Institutes of Health
Cite
APA
Srinivasu, B. Y., Damerla, T. S., Stec, A., Zhou, Z., Engen, J. R., Westover, K. D., & Wales, T. E. (2026). Magnesium as a conformational gatekeeper of KRAS : Structural dynamics and therapeutic implications. Protein Science. https://doi.org/10.1002/pro.70681
Vancouver
Srinivasu BY, Damerla TS, Stec A, Zhou Z, Engen JR, Westover KD, et al. Magnesium as a conformational gatekeeper of KRAS : Structural dynamics and therapeutic implications. Protein Science. 2026. doi:10.1002/pro.70681
BibTeX
@article{Srinivasu2026,
author = {Srinivasu, Bindu Y and Damerla, Tanvi S and Stec, Alexander and Zhou, Zhiwei and Engen, John R and Westover, Kenneth D and Wales, Thomas E},
title = {Magnesium as a conformational gatekeeper of KRAS : Structural dynamics and therapeutic implications},
journal = {Protein Science},
year = {2026},
doi = {10.1002/pro.70681}
}
EUVIMED